Purchase Short-Term Access

Significant Differential Effects of Alendronate, Estrogen, or Combination Therapy on the Rate of Bone Loss after Discontinuation of Treatment of Postmenopausal Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Susan L. Greenspan, MD; Ronald D. Emkey, MD; Henry G. Bone, MD; Stuart R. Weiss, MD; Norman H. Bell, MD; Robert W. Downs, MD; Clark McKeever, MD; Sam S. Miller, MD; Michael Davidson, MD; Michael A. Bolognese, MD, PC; Anthony L. Mulloy, PhD, DO; Norman Heyden, RPh, MS; Mei Wu, MS; Amarjot Kaur, PhD; Antonio Lombardi, MD
Annals of Internal Medicine 2002;137:875-883. doi:10.7326/0003-4819-137-11-200212030-00008

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.